Phosphorylated α-Synuclein in Parkinson’s Disease
Yu Wang(Tongji Hospital), Jing Zhang(Sichuan University), Irene Litvan(University of California, San Diego), Min Shi(Cincinnati Children's Hospital Medical Center), Elaine R. Peskind(Inserm), John Q. Trojanowski(University of Pennsylvania), Karin Srulijes(German Center for Neurodegenerative Diseases), Mya C. Schiess(The University of Texas Health Science Center at Houston), David S. Goldstein(Government of the United States of America), Poul Henning Jensen(Aarhus University), James B. Leverenz(University of Washington), Virginia M.‐Y. Lee(Institute for Neurodegenerative Disorders), Douglas Galasko(University of Minnesota), Andrew Siderowf, Xiangmin Lin(Fujian Agriculture and Forestry University), Masato Hasegawa(Tokyo Metropolitan Institute of Medical Science), Kevin C. Cain(University of Washington), Hui Yang(Capital Medical University), M. Masuda(Tokyo Metropolitan Institute of Medical Science), Catherine Pan(Mercer Island School District), Howard I. Hurtig(University of Pennsylvania), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Kathryn A. Chung(Oregon Health & Science University), Cyrus P. Zabetian(University of Washington)
Cited by 277
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k